The global pediatric drugs market is expected to grow at a CAGR of 4.5% during the forecast period, from 2021 to 2030. The growth in this market is attributed to the increasing number of pediatric patients and their growing awareness about the benefits of using these drugs. Pediatric patients are more prone to diseases such as cancer, cardiovascular diseases, and respiratory diseases than adults due to their immature immune system and other physiological differences. This has led to an increase in demand for pediatric drugs across the globe.
The global pediatric drugs market by type is segmented into allergy and respiratory drugs, antinfectives, cancer therapies, cardiovascular drugs, central nervous system (CNS) drugs, gastrointestinal (GI) drugs, hormone therapy medications for children with endocrine disorders such as diabetes mellitus or thyroid dysfunction; urological medications; vaccines; and others (e.g., analgesics). The allergy and respiratory drug segment accounted for a share of over 50% in 2017 owing to its high prevalence among children aged 0-14 years globally.
2) Increasing awareness about pediatric diseases among parents and healthcare providers is also expected to fuel demand for these products over the next few years 3) Increasing number of clinical trials on pediatric drugs will also drive growth in this market during the forecast period (2017-2022).
Some Of The Growth Factors Of This Market:
- The increasing prevalence of chronic diseases in children is one of the major factors driving the growth of this market over the forecast period (2017-2022).
Industry Growth Insights published a new data on “Pediatric Drugs Market”. The research report is titled “Pediatric Drugs Market research by Types (Allergy and Respiratory Drugs, Anti-Infectives, Cancer Therapies, Cardiovascular Drugs, Central Nervous System Drugs, Gastrointestinal Drugs, Hormone Drugs, Urological Drugs), By Applications (Hospital, Clinic, Drugstore), By Players/Companies Abbott Laboratories, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Colgate Oral Pharmaceuticals, Eli Lilly, Forest Laboratories, Genentech, GlaxoSmithKline, Johnson & Johnson, MedImmune, Merck, Novartis Pharmaceuticals, Novo Nordisk, Pfizer, Pharmacia, Roche, Schering-Plough”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Pediatric Drugs Market Research Report
By Type
Allergy and Respiratory Drugs, Anti-Infectives, Cancer Therapies, Cardiovascular Drugs, Central Nervous System Drugs, Gastrointestinal Drugs, Hormone Drugs, Urological Drugs
By Application
Hospital, Clinic, Drugstore
By Companies
Abbott Laboratories, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Colgate Oral Pharmaceuticals, Eli Lilly, Forest Laboratories, Genentech, GlaxoSmithKline, Johnson & Johnson, MedImmune, Merck, Novartis Pharmaceuticals, Novo Nordisk, Pfizer, Pharmacia, Roche, Schering-Plough
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
230
Number of Tables & Figures
161
Customization Available
Yes, the report can be customized as per your need.
Global Pediatric Drugs Market Report Segments:
The global Pediatric Drugs market is segmented on the basis of:
Types
Allergy and Respiratory Drugs, Anti-Infectives, Cancer Therapies, Cardiovascular Drugs, Central Nervous System Drugs, Gastrointestinal Drugs, Hormone Drugs, Urological Drugs
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Drugstore
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott Laboratories
- Bayer
- Boehringer Ingelheim
- Bristol-Myers Squibb
- Colgate Oral Pharmaceuticals
- Eli Lilly
- Forest Laboratories
- Genentech
- GlaxoSmithKline
- Johnson & Johnson
- MedImmune
- Merck
- Novartis Pharmaceuticals
- Novo Nordisk
- Pfizer
- Pharmacia
- Roche
- Schering-Plough
Highlights of The Pediatric Drugs Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Allergy and Respiratory Drugs
- Anti-Infectives
- Cancer Therapies
- Cardiovascular Drugs
- Central Nervous System Drugs
- Gastrointestinal Drugs
- Hormone Drugs
- Urological Drugs
- By Application:
- Hospital
- Clinic
- Drugstore
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Pediatric Drugs Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Pediatric drugs are medications specifically designed for use in children. They may be prescribed to treat a variety of conditions, including infections, cancer, and mental health issues.
Some of the major companies in the pediatric drugs market are Abbott Laboratories, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Colgate Oral Pharmaceuticals, Eli Lilly, Forest Laboratories, Genentech, GlaxoSmithKline, Johnson & Johnson, MedImmune, Merck, Novartis Pharmaceuticals, Novo Nordisk, Pfizer, Pharmacia, Roche, Schering-Plough.
The pediatric drugs market is expected to register a CAGR of 4.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Pediatric Drugs Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Pediatric Drugs Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Pediatric Drugs Market - Supply Chain
4.5. Global Pediatric Drugs Market Forecast
4.5.1. Pediatric Drugs Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Pediatric Drugs Market Size (000 Units) and Y-o-Y Growth
4.5.3. Pediatric Drugs Market Absolute $ Opportunity
5. Global Pediatric Drugs Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Pediatric Drugs Market Size and Volume Forecast by Type
5.3.1. Allergy and Respiratory Drugs
5.3.2. Anti-Infectives
5.3.3. Cancer Therapies
5.3.4. Cardiovascular Drugs
5.3.5. Central Nervous System Drugs
5.3.6. Gastrointestinal Drugs
5.3.7. Hormone Drugs
5.3.8. Urological Drugs
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Pediatric Drugs Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Pediatric Drugs Market Size and Volume Forecast by Application
6.3.1. Hospital
6.3.2. Clinic
6.3.3. Drugstore
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Pediatric Drugs Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Pediatric Drugs Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Pediatric Drugs Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Pediatric Drugs Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Pediatric Drugs Demand Share Forecast, 2019-2026
9. North America Pediatric Drugs Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Pediatric Drugs Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Pediatric Drugs Market Size and Volume Forecast by Application
9.4.1. Hospital
9.4.2. Clinic
9.4.3. Drugstore
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Pediatric Drugs Market Size and Volume Forecast by Type
9.7.1. Allergy and Respiratory Drugs
9.7.2. Anti-Infectives
9.7.3. Cancer Therapies
9.7.4. Cardiovascular Drugs
9.7.5. Central Nervous System Drugs
9.7.6. Gastrointestinal Drugs
9.7.7. Hormone Drugs
9.7.8. Urological Drugs
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Pediatric Drugs Demand Share Forecast, 2019-2026
10. Latin America Pediatric Drugs Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Pediatric Drugs Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Pediatric Drugs Market Size and Volume Forecast by Application
10.4.1. Hospital
10.4.2. Clinic
10.4.3. Drugstore
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Pediatric Drugs Market Size and Volume Forecast by Type
10.7.1. Allergy and Respiratory Drugs
10.7.2. Anti-Infectives
10.7.3. Cancer Therapies
10.7.4. Cardiovascular Drugs
10.7.5. Central Nervous System Drugs
10.7.6. Gastrointestinal Drugs
10.7.7. Hormone Drugs
10.7.8. Urological Drugs
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Pediatric Drugs Demand Share Forecast, 2019-2026
11. Europe Pediatric Drugs Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Pediatric Drugs Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Pediatric Drugs Market Size and Volume Forecast by Application
11.4.1. Hospital
11.4.2. Clinic
11.4.3. Drugstore
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Pediatric Drugs Market Size and Volume Forecast by Type
11.7.1. Allergy and Respiratory Drugs
11.7.2. Anti-Infectives
11.7.3. Cancer Therapies
11.7.4. Cardiovascular Drugs
11.7.5. Central Nervous System Drugs
11.7.6. Gastrointestinal Drugs
11.7.7. Hormone Drugs
11.7.8. Urological Drugs
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Pediatric Drugs Demand Share, 2019-2026
12. Asia Pacific Pediatric Drugs Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Pediatric Drugs Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Pediatric Drugs Market Size and Volume Forecast by Application
12.4.1. Hospital
12.4.2. Clinic
12.4.3. Drugstore
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Pediatric Drugs Market Size and Volume Forecast by Type
12.7.1. Allergy and Respiratory Drugs
12.7.2. Anti-Infectives
12.7.3. Cancer Therapies
12.7.4. Cardiovascular Drugs
12.7.5. Central Nervous System Drugs
12.7.6. Gastrointestinal Drugs
12.7.7. Hormone Drugs
12.7.8. Urological Drugs
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Pediatric Drugs Demand Share, 2019-2026
13. Middle East & Africa Pediatric Drugs Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Pediatric Drugs Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Pediatric Drugs Market Size and Volume Forecast by Application
13.4.1. Hospital
13.4.2. Clinic
13.4.3. Drugstore
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Pediatric Drugs Market Size and Volume Forecast by Type
13.7.1. Allergy and Respiratory Drugs
13.7.2. Anti-Infectives
13.7.3. Cancer Therapies
13.7.4. Cardiovascular Drugs
13.7.5. Central Nervous System Drugs
13.7.6. Gastrointestinal Drugs
13.7.7. Hormone Drugs
13.7.8. Urological Drugs
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Pediatric Drugs Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Pediatric Drugs Market: Market Share Analysis
14.2. Pediatric Drugs Distributors and Customers
14.3. Pediatric Drugs Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Abbott Laboratories
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Bayer
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Boehringer Ingelheim
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Bristol-Myers Squibb
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Colgate Oral Pharmaceuticals
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Eli Lilly
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Forest Laboratories
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Genentech
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. GlaxoSmithKline
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Johnson & Johnson
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. MedImmune
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Merck
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Novartis Pharmaceuticals
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Novo Nordisk
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. Pfizer
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. Pharmacia
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. Roche
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. Schering-Plough
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
